Cleared Traditional

K213803 - FIBERGRAFT Aeridyan Matrix Bone Graft Substitute (FDA 510(k) Clearance)

Aug 2022
Decision
260d
Days
Class 2
Risk

K213803 is an FDA 510(k) clearance for the FIBERGRAFT Aeridyan Matrix Bone Graft Substitute. This device is classified as a Filler, Bone Void, Calcium Compound (Class II - Special Controls, product code MQV).

Submitted by Prosidyan, Inc. (New Providence, US). The FDA issued a Cleared decision on August 23, 2022, 260 days after receiving the submission on December 6, 2021.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3045.

Submission Details

510(k) Number K213803 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 06, 2021
Decision Date August 23, 2022
Days to Decision 260 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code MQV - Filler, Bone Void, Calcium Compound
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3045